Lu Hongbo

Average Profitability
60.25%
Insider Buys Quantity
6
Insider Buys Sum
$12.74M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Lu Hongbo

According to the SEC Form 4 filings, Lu Hongbo, being in a position of

  1. director at Arrowhead Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 3000 shares for $82,990, and sold 0 shares,
    over all time since 2024-03-18, has bought 3000 shares for $82,990, and sold 0 shares.

The largest purchase of all time was on 2022-12-23 and amounted to 758620 shares of Terns Pharmaceuticals, Inc. for $5.5M.

Biography of Lu Hongbo

No biography is available at this moment.

2024-09-12PurchaseTerns Pharmaceuticals, Inc.
TERN
director
476,190
0.7471%
$10.50$5M-19.98%
2024-03-20PurchaseArrowhead Pharmaceuticals, Inc.
ARWR
director
1,000
0.0008%
$27.50$27,500-15.07%
2024-03-19PurchaseArrowhead Pharmaceuticals, Inc.
ARWR
director
1,000
0.0008%
$28.00$28,000-13.77%
2024-03-18PurchaseArrowhead Pharmaceuticals, Inc.
ARWR
director
1,000
0.0008%
$27.49$27,490-14.94%
2022-12-23PurchaseTerns Pharmaceuticals, Inc.
TERN
director
758,620
1.2188%
$7.25$5.5M+0.36%
2022-09-07PurchaseTerns Pharmaceuticals, Inc.
TERN
600,000
1.476%
$3.60$2.16M+120.13%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.